Position in ASND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,742,280,613
+$390,594,033 QoQ
Shares Held
10,281,496
0.0% QoQ
Ownership
15.7%
of shares outstanding
% of Portfolio
24.15%
of 13F equity value
Holder Rank
#1
of 307 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. ASND ranks #1 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
This page
|
10,281,496 | $2,742,280,613 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
28,933,371 | $791,906,364 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
6,666,837 | $740,218,912 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
11,474,599 | $667,018,439 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
9,905,045 | $435,722,929 | |
| 6 | TYRA |
Tyra Biosciences, Inc.
|
12,198,625 | $389,624,082 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
8,392,730 | $340,996,619 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,883,524 | $330,779,298 |
All Filings in ASND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,742,280,613 | 10,281,496 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,351,686,580 | 10,281,496 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,192,426,207 | 10,281,496 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,044,064,219 | 10,281,496 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,774,586,209 | 10,281,496 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,602,473,966 | 10,281,496 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,392,221,466 | 10,112,744 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,449,864,004 | 9,710,428 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,378,583,592 | 10,108,400 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,528,086,828 | 10,108,400 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,273,027,030 | 10,107,400 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,003,779,130 | 10,719,555 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,001,863,112 | 11,225,357 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $745,948,732 | 6,957,179 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $849,680,271 | 6,957,179 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $781,461,354 | 7,567,900 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $703,511,984 | 7,567,900 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $888,168,744 | 7,567,900 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,018,109,587 | 7,567,900 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,177,557,381 | 7,387,900 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $895,374,158 | 6,806,341 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $826,407,944 | 6,412,228 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $978,221,071 | 5,865,338 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $911,991,385 | 5,909,742 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $726,921,844 | 4,914,955 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $553,473,082 | 4,914,955 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||